These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6995542)

  • 1. A defect in cell-mediated immune function in insulin-resistant diabetic and obese subjects.
    Kolterman OG; Olefsky JM; Kurahara C; Taylor K
    J Lab Clin Med; 1980 Sep; 96(3):535-43. PubMed ID: 6995542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
    Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
    Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with chlorpropamide-phenformin combination in adult, obese, ketosis-resistant diabetics.
    Lev-Ran AS
    Isr J Med Sci; 1971 Jun; 7(6):727-32. PubMed ID: 4997820
    [No Abstract]   [Full Text] [Related]  

  • 7. The preservation of insulin sensitivity in obese women without diabetes.
    Ngarmukos C; Chanprasertyothin S; Puavilai G; Ongphiphadhanakul B
    J Med Assoc Thai; 2008 May; 91(5):659-64. PubMed ID: 18672628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes.
    Sivitz WI; Wayson SM; Bayless ML; Sinkey CA; Haynes WG
    J Diabetes Complications; 2007; 21(3):149-57. PubMed ID: 17493547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects.
    Belfiore F; Iannello S; Camuto M; Fagone S; Cavaleri A
    Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of valsartan on insulin sensitivity in obese, non-hypertensive subjects with and without type 2 diabetes.
    Luzio SD; Dunseath G; Owens DR
    Horm Metab Res; 2002 May; 34(5):271-4. PubMed ID: 12063642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
    Burén J; Lindmark S; Renström F; Eriksson JW
    Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diabetes mellitus vs. in vitro hyperglycemia on select immune cell functions.
    Daoud AK; Tayyar MA; Fouda IM; Harfeil NA
    J Immunotoxicol; 2009 Mar; 6(1):36-41. PubMed ID: 19519161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of obesity and insulin on immunity in non-insulin-dependent diabetes mellitus.
    Mito N; Hiyoshi T; Hosoda T; Kitada C; Sato K
    Eur J Clin Nutr; 2002 Apr; 56(4):347-51. PubMed ID: 11965511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes.
    Gosmanov AR; Umpierrez GE; Karabell AH; Cuervo R; Thomason DB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E8-E15. PubMed ID: 15010337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
    Piercy V; Toseland CD; Turner NC
    Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity to nervous system antigens in diabetic patients with neuropathy.
    Segal P; Teitelbaum D; Ohry A
    Isr J Med Sci; 1983 Jan; 19(1):7-10. PubMed ID: 6601092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance to ketosis in diabetes of the obese].
    Kodejszko E; Taton J
    Journ Annu Diabetol Hotel Dieu; 1965; 6():151-60. PubMed ID: 4956599
    [No Abstract]   [Full Text] [Related]  

  • 20. Host defense mellitus: defective membrane synthesis during phagocytosis.
    Subbaiah PV; Bagdade JD
    Horm Metab Res; 1982 Sep; 14(9):445-8. PubMed ID: 7141384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.